Angany (Canada) and Phylloceuticals (USA): two biotechnology innovators team up to accelerate Covid NAbs commercialization newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
A cocktail of monoclonal antibodies produced in plants demonstrates high neutralizing potency to fight COVID-19 and variants
March 10, 2021 GMT
Angany inc. Logo (CNW Group/Angany inc.)
QUEBEC CITY and VAL-DE-REUIL, France, March 10, 2021 /PRNewswire/ - Dr Louis-Philippe Vézina Dr Véronique Gomord (respectively CEO and CSO of Angany), and Pr. Rogier W. Sanders and Dr Marit van Gils of University Medical Centers in Amsterdam (Amsterdam UMC) announce today significant advances made in the accelerated development of a preventive and curative product based on highly potent neutralizing monoclonal antibodies (NAbs) against the SARS-CoV-02 virus and its variants.